Cellectis EPS Diluted from Extraordinaries (Quarterly) Analysis

Cellectis SA (CLLS)

3.90 -0.09 (-2.26%) USD | NASDAQ | Feb 20, 16:00

3.97 +0.07 (+1.79%) After-Hours: 20:00

View EPS Diluted from Extraordinaries (Quarterly) for CLLS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Extraordinaries (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Extraordinaries (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Extraordinaries (Quarterly) Benchmarks

Start Trial

EDAP TMS SA	--
DBV Technologies SA	--
Ascendis Pharma A/S	--
Akari Therapeutics Plc	--
Biodexa Pharmaceuticals Plc	--